- All sections
- C - Chemistry; metallurgy
- C07K - Peptides
- C07K 7/54 - Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
Patent holdings for IPC class C07K 7/54
Total number of patents in this class: 283
10-year publication summary
24
|
22
|
21
|
22
|
23
|
18
|
27
|
35
|
15
|
4
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Bristol-myers Squibb Company | 5080 |
13 |
Palatin Technologies, Inc. | 79 |
11 |
Rhythm Pharmaceuticals, Inc. | 63 |
10 |
University of South Florida | 1817 |
7 |
Novacta Biosystems Limited | 20 |
7 |
Bicyclerd Limited | 130 |
7 |
Chugai Seiyaku Kabushiki Kaisha | 1259 |
6 |
Protagonist Therapeutics, Inc. | 124 |
6 |
Shanghai Techwell Biopharmaceutical Co., Ltd. | 66 |
6 |
Ironwood Pharmaceuticals, Inc. | 165 |
5 |
Polyphor AG | 101 |
5 |
Bicycletx Limited | 149 |
5 |
President and Fellows of Harvard College | 5792 |
4 |
Aileron Therapeutics, Inc. | 85 |
4 |
The Governing Council of The University of Toronto, | 1361 |
4 |
Peptidream Inc. | 60 |
4 |
Peptinov SAS | 19 |
4 |
Zealand Pharma A/S | 211 |
4 |
Fog Pharmaceuticals, Inc. | 28 |
4 |
Bayer AG | 3045 |
3 |
Other owners | 164 |